PYPD
$11.26
Polypid
$.16
1.44%
PYPD
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.73)
Revenue:  $0.00 Mil
Wednesday
Feb 10
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PYPD reports earnings?
Beat
Meet
Miss

Where is PYPD's stock price going from here?
Up
Flat
Down
Stock chart of PYPD
Analysts
Summary of analysts' recommendations for PYPD
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
PolyPid Ltd. is a pharmaceutical company. It discovers, develops and commercializes antibiotic drugs for the prevention of surgical infections. The company's product candidate includes D-PLEX100, BONYPID-1000 and BONYPID-500 which are in clinical stage. PolyPid Ltd. is based in Petach Tikva, Israel.